FDA patent list reforms are now firmly on the US legislative agenda

FDA patent list reforms are now firmly on the US legislative agenda

Unanimous votes by the House of Representatives signal that changes to the Orange and Purple Books stand a good chance of being implemented

Unlock unlimited access to all IAM content